Страна: Новая Зеландия
Язык: английский
Источник: Medsafe (Medicines Safety Authority)
Ciprofloxacin 2 mg/mL (Equates to ciprofloxacin lactate 2.54 mg/mL in the final formulation)
Bayer New Zealand Limited
Ciprofloxacin 2 mg/mL (Equates to ciprofloxacin lactate 2.54 mg/mL in the final formulation)
2 mg/mL
Solution for infusion
Active: Ciprofloxacin 2 mg/mL (Equates to ciprofloxacin lactate 2.54 mg/mL in the final formulation) Excipient: Hydrochloric acid Lactic acid Sodium chloride Water for injection
Vial, glass, with Type I bromobutyl stopper, 50 mL
Prescription
Prescription
Bayer AG
Infections of the lower respiratory tract. In the treatment of outpatients with pneumonia due to Pneumococcus, ciprofloxacin should not be used as a medicine of first choice. Ciprofloxacin can be regarded as a suitable treatment for pneumonias caused by Klebsiella, Enterobacter, Proteus, E. coli, Pseudomonas, Haemophilus, Branhamella, Legionella, and Staphylococcus.
Package - Contents - Shelf Life: Vial, glass, with Type I bromobutyl stopper - 50 mL - 48 months from date of manufacture stored at or below 30°C - Vial, glass, with chlorobutyl stopper - 50 mL - 48 months from date of manufacture stored at or below 30°C - Vial, glass, with Type I bromobutyl stopper - 100 mL - 48 months from date of manufacture stored at or below 30°C - Vial, glass, with chlorobutyl stopper - 100 mL - 48 months from date of manufacture stored at or below 30°C - Vial, glass, with Type I bromobutyl stopper - 200 mL - 48 months from date of manufacture stored at or below 30°C - Vial, glass, with chlorobutyl stopper - 200 mL - 48 months from date of manufacture stored at or below 30°C
1990-12-18
CIPROXIN ® IV CMI 1 CIPROXIN ® IV (CI PROX IN) _ciprofloxacin _ CONSUMER MEDICINE INFORMATION WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Ciproxin IV. It does not contain all the available information. It does not take the place of talking to your doctor or your pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking Ciproxin IV against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT CIPROXIN IV IS USED FOR Ciproxin IV is used to treat serious infections in the lungs, skin, blood, bone, joints, kidneys, and bowel. Ciproxin IV is also used to treat inhalational anthrax (an infection caused by breathing in the spores of bacteria). Ciproxin IV contains the active ingredient, CIPROFLOXACIN, which is an antibiotic belonging to a group of medicines called quinolones (pronounced kwin-o-lones). These antibiotics work by killing the bacteria that are causing your infection. Ciproxin IV is used in hospitalised patients where use of Ciproxin tablets is inappropriate. Ciproxin IV will not work against infections caused by viruses such as colds or the flu. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. BEFORE YOU ARE GIVEN CIPROXIN IV _WHEN YOU MUST NOT BE _ _GIVEN IT _ YOU MUST NOT BE GIVEN CIPROXIN IV IF YOU HAVE AN ALLERGY TO: ciprofloxacin, the active ingredient in Ciproxin IV any of the ingredients listed at the end of this leaflet Прочитать полный документ
191001 Ciproxin DS Page 1 of 31 NEW ZEALAND DATA SHEET 1. CIPROXIN ® Ciproxin 250 mg, film-coated tablets* Ciproxin 500 mg, film-coated tablets* Ciproxin 750 mg, film-coated tablets* Ciproxin 50 mg/mL, oral suspension* Ciproxin 100 mg/mL, oral suspension** Ciproxin 2 mg/mL, solution for infusion* *currently unavailable ** currently available 2. QUALITATIVE AND QUANTITATIVE COMPOSITION 2.1 FILM-COATED TABLETS Ciproxin 250 mg: 1 tablet contains 291 mg ciprofloxacin hydrochloride, corresp. to 250 mg ciprofloxacin as monohydrate Ciproxin 500 mg: 1 tablet contains 582 mg ciprofloxacin hydrochloride, corresp. to 500 mg ciprofloxacin as monohydrate Ciproxin 750 mg: 1 tablet contains 873 mg ciprofloxacin hydrochloride, corresp. to 750 mg ciprofloxacin as monohydrate 2.2 ORAL SUSPENSION Ciproxin 50 mg/mL: 1 bottle consists of 7.95 g of microcapsules which contain 5.0 g ciprofloxacin 1 bottle with 99.2 g suspension diluent to prepare 100 mL of Ciproxin Suspension 5 % 1 measuring spoonful (approx. 5.0 mL) contains approx. 250 mg ciprofloxacin One measuring spoon (5.0 mL suspension) contains approx. 1.4 g of sucrose Ciproxin 100 mg/mL: 1 bottle consists of 15.9 g of microcapsules which contain 10.0 g ciprofloxacin 191001 Ciproxin DS Page 2 of 31 1 bottle with 91.7 g suspension diluent to prepare 100 mL of Ciproxin Suspension 10 % 1 measuring spoonful (approx. 5.0 mL) contains approx. 500mg ciprofloxacin One measuring spoon (5.0 mL suspension) contains approx. 1.3 g of sucrose 2.3 SOLUTION FOR INFUSION Ciproxin 2 mg/mL: 1 glass bottle of 100 mL infusion solution contains 254.4 mg ciprofloxacin lactate, corresp. to 200 mg ciprofloxacin. Sodium chloride content is 900 mg . For the full list of excipients, see _section 6.1 List of excipients. _ 3. PHARMACEUTICAL FORM 3.1 FILM-COATED TABLET Ciproxin 250 mg: Round, nearly white to slightly yellowish film-coated scored tablets marked with “CIP 250” on one side and a “Bayer cross” on the reverse side. The tablet can be divided into equal halves. Ciproxin 500 mg: Oblong, nea Прочитать полный документ